Subsidiaries
Sunrise in Tokyo, midday heat in Texas, dusk in Berlin. Three different times of day, three different worlds – yet only one name: Heyl. The reason for the success of…
Sunrise in Tokyo, midday heat in Texas, dusk in Berlin. Three different times of day, three different worlds – yet only one name: Heyl. The reason for the success of…
…to test possible interaction. Results: No difference in urine levels was observed between the administration regimens. Conclusions: A 1 h separation interval of orally administrated guar gum, known for its…
Study design: Treatment of T. gondii infected mice with various combinations of sulphadiazine and pyrimethmamine plus levamisole or echinacea to determine their influence on survival rate. Results: Combination of sulphadiazine,…
Study design: Long term prospective non-randomised trial to compare therapeutic effectiveness of corticosteroids (CS) and CS plus D-penicillamine (D-pen) in patients with severe eosionophilic fasciiti. Results: Coadministration of CS and…
The founding of Heyl Japan Co. Ltd. as the Japanese representative of HEYL, headquartered in Tokyo, took place on 26 August, 1983. The core competencies here are also mainly in…
…three times a day with 3 mg/kg body weight (RS)-2,3-Bis(sulfanyl)propane-1-sulfonic acid, sodium salt (DMPS) for 4 days. Mercury levels of blood, spot urine and 24-h urine were determined continuously. Results:…
…with insecticides from the group of organophosphates (alkyl phosphates, alkyl thiophosphates, phosphoric acid esters, thiophosphoric acid esters), e.g. Parathion = E 605® forte, in which the inhibited acetylcholinesterases can be…
Study design: This study compared several neonatal parameters of babies born by mothers with critical level of mercury in their blood who were either treated (group 1) with (RS)-2,3-Bis(sulfanyl)propane-1-sulfonic acid,…
…the hydroxo ligand linked to the trivalent cobalt ion to form cyanocobalamin. Cyanocobalamin is a stable, non-toxic compound that is excreted in the urine. The holder oft he marketing authorization…